Literature DB >> 6168691

The dual interaction of prostaglandin E2 (PGE2) and interferon (IFN) on NK lytic activation: enhanced capacity of effector-target lytic interactions (recycling) and blockage of pre-NK cell recruitment.

S R Targan.   

Abstract

In this study we addressed the question of whether the known NK activators prostaglandin E2 (PGE2) and interferon (IFN) can synergistically activate NK lysis and whether they potentiate the same or different subsets of NK cells. We demonstrated that the activation of NK lysis can be enhanced as well as blocked by the interaction of these 2 activators. The enhancement of activation was not due to recruitment of separate subsets of pre-NK cells, but rather the synergistic enhancement of the recycling capabilities of the same set of NK cells. There was a temporal relationship to this enhancement. That is, if PGE2 was added during cellular processing required for full expression of NK activation induced by IFN, pre-NK lytic potential was inhibited. If, on the other hand, PGE2 is added after completion of full expression of the IFN-induced activated lytic process, there is enhancement of recycling capabilities of the same number of NK cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6168691

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Effect of chemotherapy on NK function in the peripheral blood of cancer patients.

Authors:  D P Braun; J E Harris
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Isolation of spontaneous and interferon inducible natural killer like cells from human colonic mucosa: lysis of lymphoid and autologous epithelial target cells.

Authors:  S Targan; L Britvan; R Kendal; S Vimadalal; A Soll
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

3.  Human newborns are deficient in natural killer activity.

Authors:  J Kaplan; T C Shope; R O Bollinger; J Smith
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

Review 4.  The biology of the human natural killer cell.

Authors:  J C Roder; H F Pross
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

5.  Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon.

Authors:  K Funa; G V Alm; L Rönnblom; K Oberg
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

Review 6.  Regulation of the immune response by prostaglandins.

Authors:  J S Goodwin; J Ceuppens
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

7.  Modulation of natural killer cell activity in mice after interferon induction: depression of activity and depression of in vitro enhancement by interferon.

Authors:  R J Melder; M Ho
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Deficiency of active natural killer cells in the Chediak-Higashi syndrome. Localization of the defect using a single cell cytotoxicity assay.

Authors:  P Katz; A M Zaytoun; A S Fauci
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.